Vasculitis: all 231 studies
Page 2 of 3. Open to participants first (69), then studies with results posted, then the rest; newest registration first within each.
- A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CCX168 in Healthy ParticipantsCompletedNCT05984251Phase 1
- Livedoid Vasculopathy: Strong Association With Smoking, Weak Association With ThrombophiliaCompletedNCT05878327
- The Safety and Tolerability of STSA-1002 Following Subcutaneous Injection in Healthy SubjectsCompletedNCT05702983Phase 1
- Analysis of Imaging Features From Patients Treated With Brolucizumab in the Post-marketing Setting With Reports of Retinal Vasculitis and/or Retinal Vascular OcclusionCompletedNCT05657158
- CXCR4-PET/CT for Diagnosing Giant Cell ArteritisCompletedNCT05604482Not applicable
- Occupational and Environmental Origins of ANCA Vasculitis: Contribution of Data From the National Network for Vigilance and Prevention of Occupational Pathologies (RNV3P)Status unknownNCT05416723
- Pediatric ANCA Associated-vasculitisStatus unknownNCT05383573
- Efficacy and Safety of Secukinumab in Patients With New Onset of Giant Cell Arteritis Who Are in Clinical RemissionCompletedNCT05380453Phase 3
- Monıtorıng Glucocortıcoıd Treatment In Patıents Followed In Rheumatology ClınıcStatus unknownNCT05292456
- A Clinical Study of CD19/BCMA CAR-T Cells in the Treatment of Refractory POEMS Syndrome, Amyloidosis, Autoimmune Hemolytic Anemia, and VasculitisStatus unknownNCT05263817Early Phase 1
- COvid-19 Vaccine Booster in Immunocompromised Rheumatic DiseasesStatus unknownNCT05236491Phase 2/3
- Evolution of Neuropathies Associated With Necrotizing VasculitisTerminatedNCT05164822
- Vaccination Perception in Inflammatory Conditions - Flu, Pneumonia and COVID-19CompletedNCT05115370
- Isatuximab in Type I CryoglobulinemiaStatus unknownNCT05114109Phase 2
- National Vaccine Adverse Event Reporting Survey and EtiologyStatus unknownNCT05095844
- FDG Digital PET/CT as First Line Investigation for Giant Cell ArteritisCompletedNCT05000138
- Effect of Tofacitinib in Treating ANCA-associated VasculitisCompletedNCT04973033Not applicable
- Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Giant Cell Arteritis (GCA)CompletedNCT04930094Phase 3
- the Application of Diffusion Tensor Imaging in the Evaluation of Peripheral Neuropathy in ANCA Associated VasculitisStatus unknownNCT04923074
- Subclinical Cytomegalovirus Reactivation in Acute ANCA-associated VasculitisActive, not recruitingNCT04916704
- Patients With Co-occurrence of ANCA Vasculitis and Sjögren SyndromeCompletedNCT04895878
- Comparison of the Efficacy of Leflunomide and Azathioprine for the Maintenance Therapy of ANCA Associated VasculitisStatus unknownNCT04737343Not applicable
- Evaluation of Anti-neutrophil Cytoplasm Antibodies TestStatus unknownNCT04719715
- Plasmapheresis Before Rituximab in CryoglobulinemiaStatus unknownNCT04692363
- Giant Cell Arteritis and Differential Diagnoses Associated With Positive Temporal Artery BiopsyCompletedNCT04554290
- SLE Vasculitis In Egyptian PatientsStatus unknownNCT04386889Not applicable
- PRagmatic Analysis of Vitamin D in ANCA-Associated VasculitisCompletedNCT04280601Not applicable
- Study of the Efficacy and Safety of RPH-104 in Adult Subjects With Schnitzler SyndromeWithdrawnNCT04213274Phase 2
- Longitudinal Imaging in Patients With Large Vessel Vasculitis to Predict Further Disease CourseCompletedNCT04204876
- Predictors of Mortality in Patients With Autoimmune Diseases Admitted to the Intensive Care UnitStatus unknownNCT04022655
- Efficacy of Colchicine to Prevent Skin Relapses in Adult's IgA VasculitisStatus unknownNCT04008316Phase 3
- Rituximab and Belimumab Combination Therapy in PR3 VasculitisStatus unknownNCT03967925Phase 2
- Spontaneous Coronary Artery Dissection (SCAD) and AutoimmunityCompletedNCT03941184
- Smartphone Mindfulness Meditation for Patients With Rheumatic DiseasesTerminatedNCT03937856Not applicable
- Monitoring Large Vessel Vasculitis With PET/MR ImagingCompletedNCT03914248
- TransIent Perivascular Inflammation of the Carotid Artery (TIPIC) Syndrome: Clinical and Radiological Follow-upCompletedNCT03804112
- Evaluation of Ultrasound and PET/CT in the Diagnosis and Monitoring of Giant Cell ArteritisCompletedNCT03765424
- Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic DiseaseCompletedNCT03762824Phase 4
- Study to Determine the Hepatitis C Virus Infection Prevalence Among Patients Attended Primarily for VasculitisCompletedNCT03693586
- The Effect of Some Drugs Used in Treatment of Vasculitis on the Complement System in ChildrenStatus unknownNCT03692416Phase 3
- Automated Reading of Anti-neutrophil Cytoplasmic Autoantibodies, Indispensable Markers of VasculitisStatus unknownNCT03640078Not applicable
- Meningitis With Cerebral Vasculitis in ChildrenCompletedNCT03595761
- Study of Refractory and/or Relapsing TAkayasu aRTeritisStatus unknownNCT03543527
- Feasibility of an Immersive Virtual Reality Based Biofeedback Intervention for Outpatients in RheumatologyStatus unknownNCT03459274
- Journey of Patients With Vasculitis From First Symptom to DiagnosisCompletedNCT03410290
- Induction Therapy With Anti-TNFα vs Cyclophosphamide in Severe Behçet DiseaseCompletedNCT03371095Phase 3
- Post-Marketing Surveillance Study of OTEZLACompletedNCT03284879
- Evaluation of Macular Vascular Changes in Behcet's Disease Using Optical Coherence Tomography AngiographyCompletedNCT03264391
- Vessel Wall Imaging for Diagnosis and Monitoring of Central Nervous System (CNS) VasculitisCompletedNCT03166319Not applicable
- JOURNEY II XR Safety and Effectiveness PMCFActive, not recruitingNCT03136887
- Efficacy and Safety of H.P. ACTHAR GEL in Adults With Retinal VasculitisStatus unknownNCT03066869Phase 4
- Magnetic Resonance Imaging of Intracranial VasculopathiesStatus unknownNCT03032809
- MICRO-RNAs OF NEUTROPHILS IN RENAL ANTINEUTROPHIL CYTOPLASMIS ANTIBODY (ANCA) -ASSOCIATED VASCULITISCompletedNCT02954705
- Direct Antiviral Agents for Hepatitis C Virus-associated Cryoglobulinaemia VasculitisStatus unknownNCT02856243
- Rituximab Plus Corticosteroids in Non-infectious Active Mixed Cryoglobulinemia VasculitisTerminatedNCT02556866Phase 2
- Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity SyndromeStatus unknownNCT02550080Phase 4
- The ANCA Vasculitis Questionnaire (AAV-PRO©)CompletedNCT02507024
- Interferon-lambda: Novel Biologics for Controlling Neutrophil-mediated Pathology in Rheumatic Diseases?Status unknownNCT02498808
- Impact of Vasculitis on Employment and IncomeCompletedNCT02476292
- Pharmacokinetic Study of Rituximab Induction Regimen in ANCA-associated VasculitisTerminatedNCT02474888
- Phenomics in Autoimmune and Inflammatory DiseasesCompletedNCT02466217
- Immunogenicity of a Combined Anti-pneumococcal Vaccine Schedule in Patients With ANCA-associated VasculitisStatus unknownNCT02463578
- Residual Anti-pneumococcal Immunity After Pneumococcal Immunization in ANCA-associated VasculitisCompletedNCT02463539
- Pregnancy and Medically Assisted Conception in Rare DiseasesWithdrawnNCT02450396
- Denosumab for Glucocorticoid-treated Children With Rheumatic DisordersWithdrawnNCT02418273Phase 1/2
- The Clinical Efficacy of DFPP in Patients With AAGNTerminatedNCT02294344Not applicable
- Off-Label Use of Ribavirin in Management of Mucocutaneous Extrahepatic Manifestations of HCV InfectionStatus unknownNCT02261662Not applicable
- Vaccination in Inflammatory Rheumatic Disease (VACCIMIL). The Impact of Antirheumatic Treatment on Antibody ResponseCompletedNCT02240888Not applicable
- Low-dose Glucocorticoid Vasculitis Induction StudyStatus unknownNCT02198248Phase 4
- Educational Needs of Patients With Systemic VasculitisCompletedNCT02190929
- Vasculitis Illness Perception (VIP) StudyCompletedNCT02190916
- Differing Levels of Positive Anti-Neutrophil Cytoplasm Antibody (ANCA) Test and Their Correlation With Vasculitis or Malignancy or Chronic InflammationStatus unknownNCT02180126
- Reproductive Health in Men and Women With VasculitisCompletedNCT02176070
- Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's)CompletedNCT02108860Phase 3
- Endothelin Antagonism in ANCA VasculitisCompletedNCT02062346Not applicable
- Magnetic Resonance Angiography vs Ultrasonography in Systemic Large vEssel vasculitiSCompletedNCT02042092Not applicable
- Optical Coherence Tomography (OCT) in Retinal VasculitisCompletedNCT01998464
- Observational Study of the Genetic Architecture of Neutrophil-Mediated Inflammatory Skin DiseasesStatus unknownNCT01952275
- Immunogenicity and Safety of Vaccinations in Immunocompromised PersonsCompletedNCT01947465
- The Assessment of Prednisone In Remission Trial (TAPIR) - Patient Centric ApproachActive, not recruitingNCT01933724Phase 3
- Positron Emission Tomography of Infection and VasculitisCompletedNCT01878721
- Phase Ib Study of SC Milatuzumab in SLECompletedNCT01845740Phase 1
- IgA-positive Versus IgA-negative Immune Complex VasculitisStatus unknownNCT01815190
- Carotid Artery Neovascularization in Takayasu's and Giant Cell ArteritisCompletedNCT01795456
- PRO Development for ANCA Associated VasculitisStatus unknownNCT01729624
- The CARRA RegistryCompletedNCT01697254
- CMV Modulation of the Immune System in ANCA-associated VasculitisStatus unknownNCT01633476Phase 2
- Resistance Exercise in Rheumatic DiseaseTerminatedNCT01599260Not applicable
- BIANCA-SC: A Study of the Efficacy, Safety, and Tolerability of Blisibimod in Addition to Methotrexate During Induction of Remission in Subjects With ANCA-Associated Small Vessel VasculitisWithdrawnNCT01598857Phase 2
- Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up StudyTerminatedNCT01586858
- Plasma Exchange for Renal VasculitisTerminatedNCT01408836Phase 2/3
- Alemtuzumab for ANCA Associated Refractory VasculitisStatus unknownNCT01405807Phase 4
- Impact of Environmental Factors on Disease Activity in Spondyloarthritis (SPA): Results of the Prospective Co-Env CohortCompletedNCT01314547
- Targeting Complement Activation in Antineutrophil Cytoplasmic Autoantibodies (ANCA)-Vasculitis - EculizumabWithdrawnNCT01275287Phase 2
- Retinoids in ANCA Small Vessel Vasculitis: Silencing AutoantigensWithdrawnNCT01275274Phase 2
- Clinical Relevance of Anti-Neutrophil Cytoplasm Antibody (ANCA)in Hospitalized PatientsStatus unknownNCT01238003
- Ilaris® in Urticarial Vasculitis - Investigation of Treatment ResponsesCompletedNCT01170936Phase 2
- Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic DiseasesStatus unknownNCT01151644Phase 4
- American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification Criteria for Primary Systemic VasculitisStatus unknownNCT01066208
- Correlation of Genetic Polymorphism and Livedo VasculitisCompletedNCT00975871